In the present study, NSCLC tumour tissues had significantly lower levels of MBD2 expression than did adjacent normal tissues (data not shown), suggesting that the effect of MBD2 expression on clinical outcome may be related to demethylation. The gene discussed is MBD2; the disease is neoplasm.